awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26749281-BC5F4EDB-B877-436E-A51E-320627F78EA1
Q26749281-BC5F4EDB-B877-436E-A51E-320627F78EA1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26749281-BC5F4EDB-B877-436E-A51E-320627F78EA1
Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes
P2860
Q26749281-BC5F4EDB-B877-436E-A51E-320627F78EA1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26749281-BC5F4EDB-B877-436E-A51E-320627F78EA1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
afdf2a99ec122169fa2374aa7556af8c9c0107e7
P2860
Efficacy and safety of empagliflozin monotherapy for 52 weeks in Japanese patients with type 2 diabetes: a randomized, double-blind, parallel-group study.